COMPUMEDICS LIMITED — Director's Dealing 2016

Sep 29, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Compumedics Limited

95 006 854 897

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	David Burton
Date of last notice	7 July 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	D & DJ Burton Holdings
Date of change	30thSeptember 2016
No. of securities held prior to change	98,780,597
Class	Ordinary fully paid shares
Number acquired
Number disposed	2,777,778
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	$1,500,000.12
No. of securities held after change	96,002,819
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Sell down as part of a capital raise

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts	N/A
detailed above traded during a+closed period
where prior written clearance was required?
If so, was prior written clearance provided to allow
the trade to proceed during this period?
If prior written clearance was provided, on what
date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011